hfsa 2022: prove-hf: effect of sacubitril/valsartan in hfref pts with mr | dr james l januzzi
Published 2 years ago • 1.7K plays • Length 7:42Download video MP4
Download video MP3
Similar videos
-
5:52
esc 2022: perspective: sacubitril/valsartan & cognitive function in hfmref & hfpef
-
5:05
james januzzi, md: the prove-hf trial
-
5:12
heart failure 2022: ghrelin-hf: intravenous ghrelin in patients with hfpef | prof lars lund
-
2:50
james januzzi, md: prescribing after prove-hf findings
-
3:19
entresto for heart failure, my experience
-
6:50
new hope for heart failure patients- a gamechanger arrives
-
![【arni】ハイリスク症例でもう一度hfpefに挑む！[paraglide-hf]](https://i.ytimg.com/vi/DgOqIiulcw4/mqdefault.jpg)
34:37
【arni】ハイリスク症例でもう一度hfpefに挑む！[paraglide-hf]
-
4:20
hf 2022: clorotic: combined loop with thiazide diuretics in pts with decompensated hf | dr trullas
-
7:57
hfa 2020: eligibility for sacubitril/valsartan in hf across the ef spectrum — dr gianluigi savarese
-
26:17
sacubitril/valsartan: should we reshuffle the deck in the treatment of hf?
-
7:56
hfsa 22: heart failure recognition with micro electro-mechanical sensors | dr juuso blomster
-
2:41
hf 2022: heart failure highlights with prof giuseppe rosano
-
10:03
hrx 2022: vpexam virtual care for hf | james cireddu
-
10:31
esc 2019: primary results of the prove-hf study - harriette van spall and james januzzi
-
0:40
hearts in sf 2022 - dr. susan ehrlich
-
4:01
2022 aha/acc/hfsa guideline for hf management: highlights & implementation | dr michelle kittleson
-
28:07
view from the thoraxcenter: acc.22 late-breaking science wrap-up
-
1:21
hf 2022: chronic & acute hf guidelines for patients: improving patient adherence | prof tiny jaarsma
-
14:15
radcliffe & cardionerds @aha22: the respect epa trial
-
4:30
hfpef, a disease of the vasculature